GlucoTrack Inc.

GCTK | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.27

-$0.03 (-1.30%)

Sep 22, 2026, 1:13 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-1.30%

(1D)

Rating

Updated: Sep 5, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $1.82M

1D Range

2.23 2.29

52W Range

2.18 136.29

Valuation (TTM)

PE -0.01

PB -1.04

EV/EBITDA -0.04

Valuation (NTM)

Forward PE N/A

Forward PEG -0.00

Price Target N/A

Cash Flow

FCF Yield -900.2%

SBC Adj. FCF Yield -914.0%

SBC Impact -1.5%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y 35.1% | -5.5%

FCF 3Y | 5Y -26.7% | -36.7%

Returns

ROA -1066.7%

ROE -2135.5%

ROIC 460.0%

Financial Health

Net Cash

$1.11M

Current Ratio 0.46

Interest Coverage -54.25

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

GlucoTrack, Inc. is a medical device company that focuses on the design, development, and commercialization of novel technologies for people with diabetes. The company is developing the GlucoTrack CBG...

Sector Healthcare

Industry Medical - Devices

Employees 15

IPO Date Apr 24, 2013

Website www.glucotrack.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.